BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Maraolo AE, Gentile I, Buonomo AR, Pinchera B, Borgia G. Current evidence on the management of hepatitis B in pregnancy. World J Hepatol 2018; 10(9): 585-594 [PMID: 30310536 DOI: 10.4254/wjh.v10.i9.585]
URL: https://www.wjgnet.com/1007-9327/full/v10/i9/585.htm
Number Citing Articles
1
Alberto Enrico Maraolo. Choosing the appropriate pharmacotherapy for hepatitis B during pregnancy: what are the considerations?Expert Opinion on Pharmacotherapy 2021; 22(9): 1083 doi: 10.1080/14656566.2021.1909571
2
Lixia Chen, Peng Yue, Karen V. Lamb, Yue Zhang, Rangfang Zhu. Stigma in HBV-infected pregnant women in disclosed situations: Current status, influencing factors, and impacts on the quality of lifeApplied Nursing Research 2020; 56: 151347 doi: 10.1016/j.apnr.2020.151347
3
Shivali S. Joshi, Shan Gao, Eliana Castillo, Carla S. Coffin. Presence of Precore (C)/C Promoter Mutants in Peripheral Blood Mononuclear Cells of Chronic Hepatitis B (CHB) Carriers During Pregnancy Does Not Correlate with Increased Risk of Liver Disease in 4 Years of Follow-UpDigestive Diseases and Sciences 2020; 65(1): 204 doi: 10.1007/s10620-019-05745-w
4
Cécile Henquell. Dépistage de l’hépatite B et grossesseVocation Sage-femme 2019; 18(139): 32 doi: 10.1016/j.vsf.2019.05.007
5
Iulia Baciu, Dalila-Ana Domuncu, Tiberiu Domuncu, AncaMarina Ciobanu, Theodor Voiosu, Gheorghe Peltecu, AncaMaria Panaitescu. Tenofovir disoproxil fumarate for preventing mother-to-child transmission of hepatitis B: a literature reviewClinical and Experimental Obstetrics & Gynecology 2021; 48(1) doi: 10.31083/j.ceog.2021.01.2240